BBK Worldwide has moved! We recently changed office locations and let me tell you, it has been a time consuming and arduous process. Location, price, facilities, and staffing capacity are all important factors when it came to choosing the right location for BBK’s new corporate headquarters. As we searched for a new place to call “home,” we realized that a lot of the questions we had were similar to the questions clinical trial sponsors face when selecting sites for research studies. So, in honor of our recent move, here’s a fun, quick list of similarities between choosing a new office location and selecting sites for your research study.
Here at BBK, we’re always musing over innovative ideas for using social media in patient recruitment. But we know this has been the Achilles’ heel of the pharma industry since the beginning of time, and we get it – industry players are discouraged by IRB / EC regulations and even more discouraged by what patients might say about their brand on social media networks.
As a regular attendee of clinical trial and patient recruitment conferences, I have the chance to learn about many of the current and upcoming trends in the industry. It seems that one of the biggest trends is the use of social media as a space to promote clinical trials.
Social media listening programs observe and track social media activity, providing insights difficult to gather otherwise. When implemented in a patient recruitment campaign, these programs can gather information around a specific disease or condition, identifying active advocacy groups, common treatments, and challenges facing patients. But it goes even deeper than that, enabling you to implement the right strategies to speed your enrollment efforts.
Well, it’s finally here! T-minus one day until the 49th Annual Meeting of the Drug Information Association (DIA)! We are excited to see our old industry friends and even more excited to be hosting them in our hometown –and maybe even sharing a Stanley Cup championship! While BBK is at this year’s Annual Meeting, we’ll be up to our usual shenanigans – Tweeting up a storm, having fun at the booth, and getting serious at some sessions. Here’s a quick rundown of where you can find us and what we're up to at this year’s Annual Meeting...
- We’ll be tweeting from several different handles, so be sure to follow these BBK people to stay up to date: @BBKWorldwide, @BABresciaBBK, @AFleishmanBBK, @MStummBBK, @ABriolaBBK.
- If you’re interested in following BBK-specific tweets – follow our hashtag #BBKInsider for the latest info and updates.
- We’ll be sharing our favorite places in Boston, fun facts about our hometown, and updates on our One Fund initiative (more info below).
- Some other DIA-related “tweeps” (Twitterspeak for Twitter users) to follow for this year’s DIA: @DrugInfoAssn and @PSUChica (Courtney Ingram)
- All conference-related Tweets will be tagged with #DIA2013. To join the conversation, add the hashtag to your DIA tweets or feel free to follow the conversation by searching #DIA2013 on Twitter.com.
I wake up and fire up my computer. Instinctively I log in to Twitter and LinkedIn, to name a couple, as I want to be informed of the current happenings within the past 12 hours. I want to know how these may affect the universe, my universe, of clinical research. Through a world of hashtags, Likes, @ references or shares, I look for my profile, company, or studies that I'm involved with just to ensure that at least some or a few people have shared the information that I, so very kindly, have posted on their timelines or feeds.
BBK Worldwide, a global leader in patient recruitment, has launched Health Info Gizmo (the Gizmo), a mobile vehicle used to inform, educate, and engage patient audiences about clinical trials, and in the process, foster long-term relationships between advocacy groups and the pharmaceutical industry. By leveraging the power of collaboration, the Gizmo provides clinical trial sponsors with opportunities to engage and partner with patient advocacy organizations to advance clinical research. “Advocacy groups are hesitant to assist in the promotion of clinical trials for fear that their involvement may smatter of endorsement of one company or therapeutic direction over another,” said Aaron B. Fleishman, leader of BBK’s social innovation group. “The interesting dilemma is that, more than ever, advocacy groups want to help their constituencies by encouraging awareness of clinical trials.”
Today’s trends in global patient recruitment are creating the opportunity for greater momentum than ever before. However, it’s important to strategically use only the campaign tactics that bring the greatest value based on site capabilities and the unique study at hand. In part one of Rob’s two-part blog series, he considers today’s positive trends. Look for part two of this series next week where Rob will discuss how best to maximize these trends.
I recently joined the Partnerships in Clinical Trials Conference team for a Twitter Chat on Effective Social Media Use to Advance Clinical Trials. Social media is helping to evolve engagement with patients and physicians alike. Patients today have more opportunities to connect with each other than ever before – to share knowledge about their conditions, as well as coping strategies.
Last week, I attended the 4th Annual Summit for Clinical Ops Executives (SCOPE) conference in Miami. Unfortunately, I didn’t get as tan as I hoped; however, I did have the opportunity to lead a roundtable discussion on social media in the patient recruitment industry. This wasn’t my first rodeo. While we were discussing patient recruitment and social media, it struck me that people are done talking about it and want to start doing it. While I’m completely on board with that idea, the question still remains, “How?”